This inventor holds 4 USPTO granted patents. Top assignee: Richardson Vicks, Inc.. Active years: 1985-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1988
Title: Sergio Nacht: Innovator in Topical Treatments for Skin Inflammatory Disorders
Introduction
Sergio Nacht is a notable inventor based in Weston, CT (US), recognized for his contributions to the field of dermatology. He holds 4 patents that focus on innovative methods for treating skin inflammatory disorders. His work has significant implications for improving the quality of life for individuals suffering from these conditions.
Latest Patents
Nacht's latest patents include a method and pharmaceutical composition for topically treating skin inflammatory disorders. One patent details the use of candelilla wax or a saturated hydrocarbon fraction from candelilla wax, which comprises a mixture of saturated straight chain C.sub.29 -C.sub.33 hydrocarbons, predominantly C.sub.31 hydrocarbon. Another patent focuses on a substantially non-polar hydrocarbon fraction from beeswax, which includes a major proportion of saturated straight chain C.sub.21 -C.sub.33 hydrocarbons and a minor proportion of mono-unsaturated long chain hydrocarbons.
Career Highlights
Sergio Nacht has made significant strides in his career, particularly through his work at Richardson Vicks, Inc. His innovative approaches to topical treatments have positioned him as a key figure in the development of effective solutions for skin inflammatory disorders.
Collaborations
Nacht has collaborated with notable colleagues, including David Yeung and Eugene Gans, to further advance his research and innovations in dermatological treatments.
Conclusion
Sergio Nacht's contributions to the field of dermatology through his patents and collaborative efforts highlight his commitment to improving skin health. His innovative methods for treating skin inflammatory disorders continue to pave the way for advancements in this important area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile